Sowell Financial Services LLC Nektar Therapeutics Transaction History

Sowell Financial Services LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 07, 2021	SELL	$16.56 - $25.46 $8,180 - $12,577	-494 Closed	0 $0
Q4 2020 Jan 13, 2021	BUY	$15.77 - $19.03 $6,181 - $7,459	392 Added 384.31%	494 $8,000
Q3 2020 Nov 12, 2020	SELL	$16.59 - $24.79 $2,621 - $3,916	-158 Reduced 60.77%	102 $2,000
Q2 2020 Aug 13, 2020	SELL	$16.86 - $23.44 $52,839 - $73,460	-3,134 Reduced 92.34%	260 $6,000
Q1 2020 May 12, 2020	SELL	$14.47 - $27.96 $35,451 - $68,502	-2,450 Reduced 41.92%	3,394 $61,000
Q4 2019 Feb 07, 2020	BUY	$15.87 - $23.12 $92,379 - $134,581	5,821 Added 25308.7%	5,844 $126,000
Q3 2019 Nov 14, 2019	BUY	$16.91 - $36.27 $388 - $834	23 New	23 $0

153

131M

92.7K

4.9K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $161M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.